Pharming And Orchard Seek Stem Cell Solution To Hereditary Angioedema
Duo To Develop Hematopoietic Stem Cell Gene Therapy
Orchard Therapeutics of the US and Dutch biotech Pharming have agreed to jointly research, develop, manufacture and commercialize the former’s newly disclosed investigational ex vivo autologous hematopoietic stem cell gene therapy as a treatment for hereditary angioedema.
